← Back
$ANIP All transactions

ANI PHARMACEUTICALS INC

F

$ Value

$326K

Shares

4,269

Price

$76

Filed

Feb 13

Insider

Name

Gassert Chad

Title

SVP - CORP. DEV. & STRATEGY

CIK

0001871002

Roles

Officer

Transaction Details

Transaction Date

2026-02-11

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

69,346

Footnotes

Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,578 performance stock units, the grant of which was previously reported on April 6, 2023. | The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.

Filing Info

Accession No.

0001871002-26-000002

Form Type

4

Issuer CIK

0001023024

Gassert Chad's History

Date Ticker Type Value
2026-02-28 ANIP F $164K
2026-02-26 ANIP A $858K
2026-02-14 ANIP F $133K
2026-02-12 ANIP F $123K
2026-02-11 ANIP F $326K
2025-11-13 ANIP $8K
2025-11-12 ANIP $1.3M
2025-08-15 ANIP $1.7M

Other Insiders at ANIP (90d)

Insider Bought Sold Last
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
$357K 2026-03-11
CAREY STEPHEN P.
SVP & CFO
$552K 2026-03-07
Walsh Patrick D $445K 2026-03-03
Lalwani Nikhil
PRESIDENT & CEO
2026-03-07
Gutwerg Ori
SVP, GENERICS
$158K 2026-03-07
Mutz Christopher
HEAD OF RARE DISEASE
$1.6M 2026-03-13
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
2026-02-26
Gassert Chad
SVP - CORP. DEV. & STRATEGY
2026-02-28
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
$114K 2026-04-13
Davis Krista
SVP, CHIEF HR OFFICER
$785K 2026-03-09